Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Yahoo News Singapore
sg.news.yahoo.com > us-push-cut-drug-prices-050321449.html

US push to cut drug prices could mean longer waits for European patients

2+ hour, 33+ min ago   (942+ words) Last May, US President Donald Trump pushed to align drug pricing with the lowest levels among other developed nations — so-called most-favoured-nation (MFN) pricing. However, the pricing policy might have negative consequences. European patients might have to wait longer for some…...

Asian Business Review
asianbusinessreview.com > commentary > eastward-shift-in-biotech-world-why-india-and-china-could-lead-next-wave

The eastward shift in the biotech world: Why India and China could lead the next wave

6+ hour, 36+ min ago   (747+ words) China’s advantage is scale across discovery and development, and India in cost-efficiency and innovation footprint. For decades, the global biotechnology map was largely defined by a handful of established centres in the United States, and Europe. Boston, the Bay Area,…...

Google News
en.sedaily.com > technology > 09/14/2026 > huons-wins-three-state-drug-development-grants-with-biotech

Huons Wins Three State Drug Development Grants With Biotech Partners

6+ hour, 17+ min ago   (339+ words) Joint Projects With SurgeneX, PinotBio and PulseInMyEars Programs Span mRNA Eye Drops, ADC and Peptide Cancer Drug Huons is moving to develop drug candidates across three different modalities — an mRNA eye drop, an antibody-drug conjugate (ADC) and a peptide cancer…...

36 Kr
eu.36kr.com > en > p > 3981789068065544

AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact

6+ hour, 24+ min ago   (980+ words) When AI pushes drug design to the "minute-level", laboratories capable of validating such outputs are equally scarce. Swiss startup Adaptyv Bio completed wet experimental validation of 1320 protein sequences for Anthropic's Claude. Its revenue has increased nearly 10 times in the past…...

The Times
thetimes.com > business > companies-markets > article > gsk-lung-cancer-positive-results-jideytro-3hbmtvg3r

Lung cancer results boost GSK’s plan to rebuild oncology business

8+ hour, 35+ min ago   (58+ words) The Times Lung cancer results boost GSK’s plan to rebuild oncology business The British pharma company presents more positive data for Jideytro, which could become a first-line treatment for certain lung tumours £1 for 3 months Enjoy unlimited access to all articles....

The Republic News
therepublic.com > 09/13/2026 > lilly-fighting-black-market-for-its-next-obesity-drug

Lilly fighting black market for its next obesity drug

16+ hour, 47+ min ago   (1178+ words) Eli Lilly and Co.’s next weight-loss medication is not available. It has not been submitted for regulatory approval. It has not even completed late-stage clinical trials. But if you search “reta” or “retatrutide” on Instagram or TikTok, you will…...

Oncodaily - Oncology News
oncodaily.com > voices > servier-585580

Servier Partnering Day: Connecting Pharma, Biotech, and Academia for New Opportunities - OncoDaily

10+ hour, 42+ min ago   (107+ words) Servier shared on LinkedIn: “We are excited to announce that the next edition of the Servier Partnering Day will take place in our Paris-Saclay R/D Institute on November 23rd! This unique event is designed to bring together pharma and biotech…...

StocksToTrade
stockstotrade.com > news > edgewisetherapeuticsinc-ewtx-news-2026_09_13

Edgewise Therapeutics Jumps As EDG-7500 Data Fuels Bullish Target Hike

15+ hour, 59+ min ago   (395+ words) Edgewise Therapeutics Inc. stocks have been trading up by 7.32 percent following highly positive clinical trial advancement news. What Traders Need To Know JPMorgan lifted its price target to $60 from $53 and kept an Overweight rating after updating its model following Edgewise…...

StocksToTrade
stockstotrade.com > news > biodexapharmaceuticalsplc-bdrx-news-2026_09_13

BDRX Jumps As Biodexa Advances Phase 3 eRapa Trial

18+ hour, 59+ min ago   (385+ words) Biodexa Pharmaceuticals plc stocks have been trading up by 82.49 percent amid heightened optimism over its latest clinical progress What Traders Need To Know Phase 3 Serenta trial of eRapa in Familial Adenomatous Polyposis has passed halfway enrollment, with 87 of 168 patients recruited…...

TheStreet Pro
pro.thestreet.com > trade-ideas > how-to-trade-this-2-billion-biotech-name-moving-quickly-toward-profit

How to Trade This $2 Billion Biotech Name Moving Quickly Toward Profit

16+ hour, 36+ min ago   (424+ words) Here’s our covered-call idea. The first full trading week of September was an eventful one. There was the 25th anniversary of the 9/11 attacks on Friday. Hostilities also escalated notably across the Middle East. This pushed oil up sharply with Brent and…...